| Application of 3D printing technology and quality by design approach for development of age-appropriate pediatric formulation of baclofen S Palekar, PK Nukala, SM Mishra, T Kipping, K Patel International journal of pharmaceutics 556, 106-116, 2019 | 165 | 2019 |
| Abuse deterrent immediate release egg-shaped tablet (Egglets) using 3D printing technology: quality by design to optimize drug release and extraction PK Nukala, S Palekar, M Patki, K Patel Aaps Pharmscitech 20, 1-12, 2019 | 96 | 2019 |
| Investigating the application of FDM 3D printing pattern in preparation of patient-tailored dosage forms PK Nukala, S Palekar, N Solanki, Y Fu, M Patki, AA Shohatee, ... Journal of 3D printing in medicine 3 (1), 23-37, 2019 | 55 | 2019 |
| Process optimization of twin-screw melt granulation of fenofibrate using design of experiment (DoE) HK Mamidi, S Palekar, PK Nukala, SM Mishra, M Patki, Y Fu, P Supner, ... International Journal of Pharmaceutics 593, 120101, 2021 | 35 | 2021 |
| Multi-dose oral abuse deterrent formulation of loperamide using hot melt extrusion PK Nukala, S Palekar, M Patki, Y Fu, K Patel International journal of pharmaceutics 569, 118629, 2019 | 28 | 2019 |
| Self-injectable extended release formulation of Remdesivir (SelfExRem): A potential formulation alternative for COVID-19 treatment M Patki, S Palekar, S Reznik, K Patel International Journal of Pharmaceutics 597, 120329, 2021 | 16 | 2021 |
| Nanocrystals for controlled delivery: state of the art and approved drug products RS Kalhapure, S Palekar, K Patel, J Monpara Expert opinion on drug delivery 19 (10), 1303-1316, 2022 | 15 | 2022 |
| Aversion liquid-filled drug releasing capsule (3D-RECAL): A novel technology for the development of immediate release abuse deterrent formulations using a fused deposition … S Palekar, PK Nukala, K Patel International Journal of Pharmaceutics 621, 121804, 2022 | 12 | 2022 |
| Abuse deterrent immediate release film technology (ADRIFT): A novel bilayer film technology for limiting intentional drug abuse S Palekar, PK Nukala, R Vartak, K Patel International Journal of Pharmaceutics 590, 119944, 2020 | 12 | 2020 |
| Ibrutinib amorphous solid dispersions with enhanced dissolution at colonic pH for the localized treatment of colorectal cancer H Patel, S Palekar, A Patel, K Patel International Journal of Pharmaceutics 641, 123056, 2023 | 11 | 2023 |
| Overdose and alcohol sensitive immediate release system (OASIS) for deterring accidental overdose or abuse of drugs M Patki, S Palekar, PK Nukala, R Vartak, K Patel Aaps Pharmscitech 22, 1-12, 2021 | 10 | 2021 |
| Development of a safe pediatric liquisolid self-nanoemulsifying system of triclabendazole for the treatment of fascioliasis S Daware, M Patki, A Saraswat, S Palekar, K Patel International Journal of Pharmaceutics 626, 122163, 2022 | 8 | 2022 |
| Tunable Drug Release from Fused Deposition Modelling (FDM) 3D-Printed Tablets Fabricated Using a Novel Extrudable Polymer V Raje, S Palekar, S Banella, K Patel Pharmaceutics 14 (10), 2192, 2022 | 7 | 2022 |
| Corroborating various material-sparing techniques with hot melt extrusion for the preparation of triclabendazole amorphous solid dispersions S Palekar, HK Mamidi, Y Guo, R Vartak, K Patel International Journal of Pharmaceutics 640, 122989, 2023 | 4 | 2023 |
| Tunable drug release from fused deposition modelling (FDM) 3D-printed tablets fabricated using a novel extrudable polymer. Pharmaceutics. 2022; 14: 2192. MDPI V Raje, S Palekar, S Banella, K Patel s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2022 | 1 | 2022 |
| Formulation strategies for the development of high drug-loaded amorphous solid dispersions H Mamidi, S Palekar, H Patel, PK Nukala, K Patel Drug Discovery Today, 103806, 2023 | | 2023 |
Ketan PatelAssociate Professor, St John's UniversityAdresse e-mail validée de stjohns.edu
